Physician profile
Sergio Jaramillo
NPI 1679770879
$31,807.14
in general payments reported to CMS, 2019-2025
78 companies · $5,653 in 2025
The $5,653 reported for 2025 was more than what 89% of Sleep Medicine (Psychiatry & Neurology) providers received nationally (typical 2025 total: $337).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $1,459 · 2020: $2,468 · 2021: $8,313 · 2022: $2,805 · 2023: $6,169 · 2024: $4,940 · 2025: $5,653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Travel and Lodging: $1,811 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,263 · Education: $711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,977.12 |
| Travel and Lodging | $1,811.34 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,263.11 |
| Education | $710.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $6,865.89 | 2020-2025 | |
| Ucb, INC. | $4,014.38 | 2019-2025 | Briviact, Nayzilam, Fintepla |
| Pfizer INC. | $1,675.31 | 2023-2025 | |
| Abbott Laboratories | $1,663.80 | 2020-2023 | Infinity, Proclaim |
| Inspire Medical Systems, INC. | $1,368.02 | 2023-2025 | Inspire |
| Teva Pharmaceuticals USA, INC. | $1,105.80 | 2019-2025 | Austedo Xr, Austedo, Austedo Xr |
| Allergan, INC. | $1,084.09 | 2019-2022 | |
| Neurocrine Biosciences, INC. | $1,073.40 | 2019-2025 | Ingrezza, Ongentys |
| Amgen INC. | $1,054.98 | 2019-2025 | Uplizna |
| Jazz Pharmaceuticals INC. | $939.58 | 2020-2025 | |
| Eisai INC. | $938.24 | 2019-2025 | |
| Lilly USA, LLC | $745.48 | 2019-2025 | Amyvid, Kisunla, Zepbound |
| Harmony Biosciences LLC | $723.84 | 2020-2025 | Wakix |
| Novartis Pharmaceuticals Corporation | $644.26 | 2020-2025 | |
| Alexion Pharmaceuticals, INC. | $415.45 | 2019-2025 | Ultomiris |
Show all 76 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $370.87 | 2021-2023 | Gralise |
| Tanabe Pharma America, INC. | $347.91 | 2019-2025 | Radicava |
| Adamas Pharmaceuticals, INC. | $329.29 | 2019-2021 | |
| Lundbeck LLC | $326.38 | 2020-2025 | Vyepti, Rexulti |
| Mdd US Operations, LLC | $309.97 | 2019-2025 | Apokyn |
| Otsuka America Pharmaceutical, INC. | $305.60 | 2023-2024 | Rexulti, Nuedexta |
| Argenx US, INC. | $264.38 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Sk Life Science, INC. | $254.06 | 2020-2023 | |
| Merz Pharmaceuticals, LLC | $251.79 | 2022-2025 | Xeomin, Inbrija, Ampyra |
| Axsome Therapeutics, INC. | $245.56 | 2024-2025 | Sunosi, Symbravo |
| Neurelis, INC. | $244.72 | 2020-2025 | Valtoco |
| Mallinckrodt Hospital Products INC. | $241.21 | 2020-2025 | Acthar |
| Acorda Therapeutics, INC | $235.43 | 2019-2023 | Inbrija |
| Boston Scientific Corporation | $224.89 | 2019-2023 | Watchman Flx |
| Biogen, INC. | $211.54 | 2020-2025 | Tysabri, Vumerity, Plegridy |
| Amneal Pharmaceuticals LLC | $174.67 | 2024-2025 | Crexont, Ongentys, Ongentys 50mg Capsules 30 |
| Sunovion Pharmaceuticals INC. | $172.49 | 2019-2022 | |
| Janssen Biotech, INC. | $156.68 | 2025 | |
| Avadel Cns Pharmaceuticals, LLC | $155.90 | 2024-2025 | Lumryz |
| Octapharma USA, INC. | $149.06 | 2022-2025 | Panzyga |
| Biohaven Pharmaceuticals, INC. | $148.19 | 2020-2021 | |
| Tg Therapeutics, INC. | $147.14 | 2023-2025 | |
| Insightec,INC | $138.96 | 2023 | Exablate |
| Upsher-Smith Laboratories LLC | $128.87 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $125.19 | 2023 | Aptiom |
| Biohaven Pharmaceutical Holding Company LTD. | $124.32 | 2022 | |
| Aprecia Pharmaceuticals, LLC | $115.14 | 2020-2023 | Spritam |
| Astrazeneca Pharmaceuticals LP | $113.05 | 2021-2025 | Wainua |
| Zyla Life Sciences, INC. | $105.77 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $100.18 | 2022-2023 | Ponvory |
| Genentech USA, INC. | $95.60 | 2025 | Ocrevus Zunovo, Ocrevus |
| Aquestive Therapeutics, INC. | $95.03 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $94.04 | 2023-2025 | Hyqvia, Gammagard |
| Grifols USA, LLC | $83.05 | 2020-2025 | Gamunex-C |
| Banner Life Sciences, LLC | $77.72 | 2021-2024 | |
| Acadia Pharmaceuticals INC | $77.02 | 2020-2023 | Nuplazid |
| Livanova USA, INC. | $72.04 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Kyowa Kirin, INC. | $69.64 | 2019-2024 | Nourianz |
| Celgene Corporation | $50.13 | 2020-2024 | Zeposia |
| Avion Pharmaceuticals | $49.35 | 2022 | |
| Vanda Pharmaceuticals INC. | $45.34 | 2020-2025 | Ponvory |
| Greenwich Biosciences, INC. | $39.25 | 2020 | |
| C2n Diagnostics, LLC | $38.03 | 2025 | Precivityad2 |
| Horizon Therapeutics Plc | $36.23 | 2021-2023 | Uplizna |
| Cycle Pharmaceuticals INC | $33.97 | 2025 | Bafiertam |
| Philips North America LLC | $30.09 | 2019 | |
| Averitas Pharma INC. | $27.78 | 2023 | Qutenza |
| Ge Healthcare | $25.90 | 2023 | |
| Itamar Medical INC | $25.82 | 2023 | Watchpatone |
| Alnylam Pharmaceuticals INC. | $24.41 | 2025 | Givlaari |
| Currax Pharmaceuticals LLC | $23.14 | 2021 | |
| Alfasigma USA, INC. | $20.91 | 2022 | |
| Supernus Pharmaceuticals, INC. | $20.59 | 2021 | |
| Vertical Pharmaceuticals, LLC | $18.71 | 2019 | |
| Microtransponder, INC. | $18.26 | 2025 | |
| Akcea Therapeutics, INC. | $17.35 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.69 | 2020 | |
| Avanir Pharmaceuticals, INC. | $13.96 | 2019 | |
| Assertio Therapeutics, INC. | $13.53 | 2019 | |
| Life Molecular Imaging LTD | $11.83 | 2019 | |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$105,822.66 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergio Jaramillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.